Prof. Guus Rimmelzwaan, Scientific Coordinator of FLUNIVAC

Prof. Guus Rimmelzwaan

Scientific Coordinator of FLUNIVAC, based at Erasmus University Medical Centre in Rotterdam, the Netherlands

Research field

Virology, Infectious Diseases

If you like this
If you want to know more
Research Profile


Guus Rimmelzwaan is Professor of Immunovirology at the Erasmus University Medical Centre in Rotterdam. He has a long standing track record of investigating immunity to influenza virus infections. “Working on the ‘Holy Grail’, the development of a universal influenza vaccine, is a major and motivating challenge for me”, he says.


Flu claims more lives each year than traffic. Effectively protecting the population from seasonal and pandemic influenza has proven to be a challenge. The virus mutates rapidly, so vaccine production is constantly lagging behind. Current influenza vaccines fail to provide long-lasting and broad protection against influenza.


FLUNIVAC aims to develop a novel influenza vaccine that protects against multiple influenza strains. Influenza, commonly known as the flu, is a viral infection of the respiratory tract. Influenza viruses cause regular epidemics of flu (seasonal flu). They occasionally cause pandemics such as the 2009 Mexican flu.


FLUNIVAC is a collaborative research project funded by the EU. The novel vaccine will contain one or more proteins that are essential for the influenza virus life cycle. The vaccine should protect against a broad range of flu viruses by inducing two types of immune response in the body: antibody-mediated and T-cell-mediated.

Developing a universal flu vaccine

In the Picture
In the Picture
Image credits

Background image: James Gathany, Centers for Disease Control and Prevention

Portrait of the project coordinator: FLUNIVAC

Timeline (in chronological order): 1599: Kat Masback; 1898: Wikipedia; 1918: USArmy photographer; 1968-69: UC Davis; 2009: C. S. Goldsmith and A. Balish, CDC; 2013-chickens: Jayme Frye; 2013-vaccination: AJ Cann